Dr Tay Miah Hiang, Senior Consultant Medical Oncologist at OncoCare Cancer Centre, was previously a consultant at the National Cancer Centre Singapore’s Department of Medical Oncology, and Chairperson of Patient Education & Patient Survivorship programs. Dr Tay also served on the board of the Singapore Children’s Cancer Foundation from 2006 to 2015, was Chairperson of this foundation from 2011 to 2013, and now serving as advisor. He has been an elected member of the Singapore Medical Council (SMC) since 2017 till date.

Dr Tay is passionate about contributing to Continuous Medical Education in the region, giving lectures in cancer management to cancer specialists, general practitioners, medical students, and patients. He has won numerous awards for his service excellence and humanity contribution to disaster-inflicted regions such as the post-Afghanistan war and Sri Lanka after the Tsunami.

He has been actively involved in clinical and translational research for many years, in genitourinary (testicular, kidney, bladder, prostate), lung, and other cancers. His research work is well-published in hormone-refractory prostate cancer involving chemotherapy agents such as docetaxel and carboplatin. Acknowledged as a senior cancer specialist and an authority in prostate cancer in Singapore, he had also published on the use of ketoconazole and as part of a multi-centre clinical trial, the use of abiraterone acetate in metastatic castration-resistant prostate cancer progressing after chemotherapy.

As a pioneer in kidney cancer oncology, he had used sunitinib (Sutent), and refametinib in kidney cancer patients when the drugs were coming into clinical practice in Singapore. Recognised as an authority on prostate cancer in Singapore, he helped develop guidelines for the treatment of prostate cancer in Singapore in 2013 and the management of kidney cancer in Asia at the Asian Oncology Summit in 2012.

His significant research work has been published in both local and international journals including Urology, Cancer, and Annals of Oncology. He also wrote chapters in several internationally recognised cancer specialty books such as Comprehensive Textbook of Genitourinary Oncology (3rd Edition), American Cancer Society’s Complete Guide to Prostate Cancer 2006, and Textbook on Urologic Oncology 2004.

Dr Tay is lauded for his experience in treating prostate, kidney, testicular, and bladder, gynaecological cancers such as ovarian cancer and uterine/cervical cancers, gastrointestinal & hepatobiliary cancers, lung cancer, and brain tumour.  He does not see patients with lymphoma, leukemia, and breast cancer.